Liver receptor homolog 1 contributes to intestinal tumor formation through effects on cell cycle and inflammation
AUTOR(ES)
Schoonjans, Kristina
FONTE
National Academy of Sciences
RESUMO
Liver receptor homolog 1 (LRH-1) is an orphan nuclear receptor that synergizes with β-catenin/T cell factor 4 signaling to stimulate intestinal crypt cell renewal. We evaluated here the impact of haploinsufficiency of LRH-1 on intestinal tumorigenesis by using two independent mouse models of human colon tumorigenesis. Haploinsufficiency of LRH-1 blunts intestinal tumorigenesis in the ApcMin/+ mice, a genetic model of intestinal cancer. Likewise, Lrh-1+/– mice are protected against the formation of aberrant crypt foci in the colon of mice exposed to the carcinogen azoxymethane. LRH-1 gene expression is reduced in tumors that express elevated levels of the proinflammatory cytokine TNF-α. Reciprocally, decreased LRH-1 expression in Lrh-1+/– mice attenuates TNF-α expression. Compared with normal human colon, expression and subcellular localization of LRH-1 is significantly altered in neoplastic colon. In combination, these data suggest a role of LRH-1 in the initiation of intestinal tumorigenesis both by affecting cell cycle control as well as through its impact on inflammatory pathways.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=548586Documentos Relacionados
- Paternal and maternal genomes confer opposite effects on proliferation, cell-cycle length, senescence, and tumor formation
- Dysregulated LIGHT expression on T cells mediates intestinal inflammation and contributes to IgA nephropathy
- Hypoxia-Mediated Up-Regulation of Pim-1 Contributes to Solid Tumor Formation
- Inhibitory Effects of a Pectin-Enriched Tomato Cell Wall Fraction on Agrobacterium tumefaciens Binding and Tumor Formation 1
- Transcriptional Activation of Cyclin D1 Promoter by FAK Contributes to Cell Cycle Progression